Alexio Capovilla

In 2005, Alexio was appointed to the Department of Molecular Medicine and Haematology and co-director of the HIV Pathogenesis Research Laboratory (HPRL). Here he used extensive experience gained in virological research to pursue a budding interest in the biology of HIV.

At HPRL, he began investigating various aspects of the mechanism of HIV-1 entry into host cells, research that is directly applicable to the development of novel HIV-1 therapeutic compounds, vaccine immunogens and recombinant diagnostic products.

Alexio’s research career has involved temporary positions at collaborating laboratories in France (Laboratoire du Radiosensibilite, Commisariat a l’Energie Atomique (CEA), Paris) and Sweden (Medical Biochemistry and Biophysics, Medical Nobel Institute, Karolinska Institutet, Stockholm).